Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Depression as a predictor of occupational transition in a multiple sclerosis cohort.
The role of assessment in enhancing the vocational success of people with multiple sclerosis.
Tolerogenic vaccines for Multiple sclerosis.
Multiple sclerosis: Imaging of central veins in brain lesions can be used to predict multiple sclerosis.
Multiple sclerosis: autoimmunity and viruses.
Patient assessment within the context of healthcare delivery packages: A comparative analysis.
Erratum to: Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis.
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Time matters - Acute stress response and glucocorticoid sensitivity in early multiple sclerosis.
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.
Lipocalin-2 deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders.
Onset of neuromyelitis optica in the elderly.
Disease activity return after natalizumab cessation in multiple sclerosis.
Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction.
Stem cell therapy in multiple sclerosis: a future perspective.
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis.
Smoking and multiple sclerosis susceptibility.
Nutritional factors and aging in demyelinating diseases.
The Potential Roles of Aquaporin 4 in Alzheimer's Disease.
Ventricular arrhythmia in a male MS patient on fingolimod.
[Immunomodulatory effect of Huangqi glycoprotein on mice with experimental autoimmune encephalomyelitis].
Cigarette smoke inhibits efferocytosis via deregulation of sphingosine kinase signaling: reversal with exogenous S1P and the S1P analogue FTY720.
Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS).
Pages
« first
‹ previous
…
577
578
579
580
581
582
583
584
585
…
next ›
last »